Template:Nucleic acid inhibitors: Difference between revisions
Content deleted Content added
Mark Sarafloxacin as withdrawn |
Innerstream (talk | contribs) No edit summary |
||
| (14 intermediate revisions by 9 users not shown) | |||
| Line 1: | Line 1: | ||
{{Navbox |
{{Navbox |
||
| name = Nucleic acid inhibitors |
| name = Nucleic acid inhibitors |
||
| title = [[Antibiotics|Antibacterials]] |
| title = [[Antibiotics|Antibacterials]] that [[nucleic acid inhibitor|inhibit nucleic acid]] ([[ATC code J01#J01E|J01E]], [[ATC code J01#J01M|J01M]]) |
||
| state = {{{state<includeonly>|autocollapse</includeonly>}}} |
| state = {{{state<includeonly>|autocollapse</includeonly>}}} |
||
| listclass = hlist |
| listclass = hlist |
||
| group1 = [[Antifolate]]s<br |
| group1 = [[Antifolate]]s<br/>(inhibit bacterial<br/>[[purine metabolism|purine metabolism]],<br/>thereby inhibiting<br/>DNA and RNA<br/>synthesis) |
||
| list1 = {{Navbox|child |
| list1 = {{Navbox|child |
||
| Line 11: | Line 11: | ||
| list1 = |
| list1 = |
||
* [[2,4-Diaminopyrimidine]] |
* [[2,4-Diaminopyrimidine]] |
||
| ⚫ | |||
** [[Brodimoprim]] |
** [[Brodimoprim]] |
||
| ⚫ | |||
** [[Iclaprim]]<sup>†</sup> |
** [[Iclaprim]]<sup>†</sup> |
||
** [[Ormetoprim]] |
|||
** [[Pyrimethamine]]<sup>#</sup> |
|||
| ⚫ | |||
| ⚫ | |||
| group2 = [[Sulfonamide (medicine)|Sulfonamides]]<br />([[Dihydropteroate synthetase inhibitor|DHPS inhibitor]]) |
| group2 = [[Sulfonamide (medicine)|Sulfonamides]]<br />([[Dihydropteroate synthetase inhibitor|DHPS inhibitor]]) |
||
| list2 = {{Navbox|child |
| list2 = {{Navbox|child |
||
| group1 = [[Sulfonamide (medicine)#Short-acting|Short- |
| group1 = [[Sulfonamide (medicine)#Short-acting|Short-acting]] |
||
| list1 = |
| list1 = |
||
* [[Sulfisomidine|Sulfaisodimidine]] |
* [[Sulfisomidine|Sulfaisodimidine]] |
||
* [[Sulfamethizole]] |
* [[Sulfamethizole]] |
||
* [[Sulfadimidine]] |
* [[Sulfadimidine]] |
||
* [[Sulfapyridine]] |
* [[Sulfapyridine]] ([[Sulfasalazine]]) |
||
* [[Sulfafurazole]] |
* [[Sulfafurazole]] ([[Acetyl sulfisoxazole]]) |
||
* [[Sulfanilamide]] |
* [[Sulfanilamide]] |
||
** [[Prontosil]] |
** [[Prontosil]] |
||
* [[Sulfathiazole]] |
* [[Sulfathiazole]] ([[Phthalylsulfathiazole]], [[Succinylsulfathiazole]]) |
||
* [[Sulfathiourea]] |
* [[Sulfathiourea]] |
||
| group2 = [[Sulfonamide (medicine)#Intermediate-acting|Intermediate- |
| group2 = [[Sulfonamide (medicine)#Intermediate-acting|Intermediate-acting]] |
||
| list2 = |
| list2 = |
||
* [[Sulfamethoxazole]] |
* [[Sulfamethoxazole]] |
||
| Line 37: | Line 39: | ||
* [[Sulfamoxole]] |
* [[Sulfamoxole]] |
||
| group3 = [[Sulfonamide (medicine)#Long-acting|Long- |
| group3 = [[Sulfonamide (medicine)#Long-acting|Long-acting]] |
||
| list3 = |
| list3 = |
||
* [[Sulfadimethoxine]] |
* [[Sulfadimethoxine]] |
||
| Line 52: | Line 54: | ||
| group4 = Other/ungrouped |
| group4 = Other/ungrouped |
||
| list4 = |
| list4 = |
||
* [[Mafenide]] |
|||
* [[Sulfacetamide]] |
* [[Sulfacetamide]] |
||
* [[Sulfaclozine]] |
|||
* [[Sulfadicramide]] |
* [[Sulfadicramide]] |
||
* [[Sulfaguanidine]] |
|||
* [[Sulfametrole]] |
* [[Sulfametrole]] |
||
* [[Sulfanitran]] |
* [[Sulfanitran]] |
||
| Line 63: | Line 68: | ||
* [[Trimethoprim/sulfamethoxazole]]<sup>#</sup> |
* [[Trimethoprim/sulfamethoxazole]]<sup>#</sup> |
||
* [[Sulfadimethoxine#with ormetoprim|Ormetoprim/sulfadimethoxine]] |
* [[Sulfadimethoxine#with ormetoprim|Ormetoprim/sulfadimethoxine]] |
||
* [[Pyrimethamine/dapsone]] |
|||
* [[Pyrimethamine/sulfadoxine]] |
|||
| Line 68: | Line 75: | ||
| group4 = Other DHPS inhibitors |
| group4 = Other DHPS inhibitors |
||
| list4 = |
| list4 = |
||
* [[Acediasulfone]] |
|||
* [[Dapsone]] |
* [[Dapsone]] |
||
* [[Solasulfone]] |
|||
* [[Sulfoxone]] |
|||
}} |
}} |
||
| group2 = [[ |
| group2 = [[Quinolone antibiotic|Quinolone]]s<br/>(inhibit bacterial<br/>[[Topoisomerase inhibitor|topoisomerase]]<br/>and/or [[DNA gyrase|DNA gyrase]],<br/>thereby inhibiting<br/>[[DNA replication]]) |
||
| list2 = {{Navbox|child |
| list2 = {{Navbox|child |
||
| group1 = [[Quinolone antibiotic#First generation|1st |
| group1 = [[Quinolone antibiotic#First generation|1st generation]] |
||
| list1 = |
| list1 = |
||
* [[Cinoxacin]]<sup>‡</sup> |
* [[Cinoxacin]]<sup>‡</sup> |
||
| Line 86: | Line 95: | ||
* [[Rosoxacin]]<sup>‡</sup> |
* [[Rosoxacin]]<sup>‡</sup> |
||
| group2 = |
| group2 = [[Quinolone antibiotic|Fluoroquinolones]] |
||
| list2 = {{Navbox|child |
| list2 = {{Navbox|child |
||
| group1 = [[Quinolone antibiotic#Second generation|2nd |
| group1 = [[Quinolone antibiotic#Second generation|2nd generation]] |
||
| list1 = |
| list1 = |
||
* [[Ciprofloxacin]]<sup>#</sup> |
* [[Ciprofloxacin]]<sup>#</sup> |
||
| Line 96: | Line 105: | ||
* [[Fleroxacin]]<sup>‡</sup> |
* [[Fleroxacin]]<sup>‡</sup> |
||
* [[Lomefloxacin]]<sup>‡</sup> |
* [[Lomefloxacin]]<sup>‡</sup> |
||
* [[Nadifloxacin]]<sup>‡</sup> |
* [[Nadifloxacin]]<sup>‡</sup>/[[Levonadifloxacin]]/[[Alalevonadifloxacin]] |
||
* [[Norfloxacin]]<sup>‡</sup> |
* [[Norfloxacin]]<sup>‡</sup> |
||
* [[Pefloxacin]]<sup>‡</sup> |
* [[Pefloxacin]]<sup>‡</sup> |
||
* [[Rufloxacin]]<sup>‡</sup> |
* [[Rufloxacin]]<sup>‡</sup> |
||
| group2 = [[Quinolone antibiotic#Third generation|3rd |
| group2 = [[Quinolone antibiotic#Third generation|3rd generation]] |
||
| list2 = |
| list2 = |
||
* [[Levofloxacin]]<sup>#</sup> |
* [[Levofloxacin]]<sup>#</sup> |
||
| Line 111: | Line 120: | ||
* [[Tosufloxacin]]<sup>‡</sup> |
* [[Tosufloxacin]]<sup>‡</sup> |
||
| group3 = [[Quinolone antibiotic#Fourth generation|4th |
| group3 = [[Quinolone antibiotic#Fourth generation|4th generation]] |
||
| list3 = |
| list3 = |
||
* [[Besifloxacin]] |
* [[Besifloxacin]] |
||
* [[Delafloxacin]] |
|||
* [[Gatifloxacin]] |
* [[Gatifloxacin]] |
||
* [[Finafloxacin]] |
* [[Finafloxacin]] |
||
* [[Gemifloxacin]] |
* [[Gemifloxacin]] |
||
* [[Moxifloxacin]] |
* [[Moxifloxacin]]<sup>#</sup> |
||
* [[Clinafloxacin]]<sup>†</sup> |
* [[Clinafloxacin]]<sup>†</sup> |
||
* [[Garenoxacin]]<sup>‡</sup> |
* [[Garenoxacin]]<sup>‡</sup> |
||
| Line 125: | Line 135: | ||
| group4 = [[Quinolone antibiotic#Veterinary use| |
| group4 = [[Quinolone antibiotic#Veterinary use|Veterinary]] |
||
| list4 = |
| list4 = |
||
* [[Danofloxacin]] |
* [[Danofloxacin]] |
||
| Line 140: | Line 150: | ||
| list3 = |
| list3 = |
||
* [[Nemonoxacin]] |
* [[Nemonoxacin]] |
||
* [[Ozenoxacin]] |
|||
| group4 = Related ([[DNA gyrase|DG]]) |
| group4 = Related ([[DNA gyrase|DG]]) |
||
| Line 149: | Line 160: | ||
| list3 = {{Navbox|child |
| list3 = {{Navbox|child |
||
| group1 = [[Nitroimidazole |
| group1 = [[Nitroimidazole]] derivatives |
||
| list1 = |
| list1 = |
||
* [[Metronidazole]]<sup>#</sup> |
* [[Metronidazole]]<sup>#</sup> |
||
| ⚫ | |||
* [[Ornidazole]] |
* [[Ornidazole]] |
||
* [[Secnidazole]] |
|||
| ⚫ | |||
| group2 = [[Nitrofuran]] derivatives |
| group2 = [[Nitrofuran]] derivatives |
||
| list2 = |
| list2 = |
||
| ⚫ | |||
* [[Furazolidone]]<sup>‡</sup> |
* [[Furazolidone]]<sup>‡</sup> |
||
* [[Nifuroxazide]] |
|||
* [[Nifurtoinol]] |
* [[Nifurtoinol]] |
||
* [[Nifurzide]] |
|||
| ⚫ | |||
* [[Nitrofurazone]] |
|||
}} |
}} |
||
| Line 173: | Line 188: | ||
* [[Rifaximin]] |
* [[Rifaximin]] |
||
* [[Rifalazil]]<sup>§</sup> |
* [[Rifalazil]]<sup>§</sup> |
||
| group2 = [[Lipiarmycin]]s |
|||
| list2 = |
|||
* [[Fidaxomicin]] |
|||
}} |
}} |
||
Latest revision as of 17:15, 4 May 2024
This template's initial visibility currently defaults to autocollapse, meaning that if there is another collapsible item on the page (a navbox, sidebar, or table with the collapsible attribute), it is hidden apart from its title bar; if not, it is fully visible.
To change this template's initial visibility, the |state= parameter may be used:
{{Nucleic acid inhibitors|state=collapsed}}will show the template collapsed, i.e. hidden apart from its title bar.{{Nucleic acid inhibitors|state=expanded}}will show the template expanded, i.e. fully visible.